Additionally, we identified known genes or pathways that control immunogenicity in cancer cells, including PRMT5 (18, 21), ADAR (22), cell cycle (CDK5R1, RPTOR), and the immune suppression related gene TGFBRAP1 (Figure 2F). This evidence concerns the gene RPTOR and cancer.